Dr. Christine Parseghian
Claim this profileM D Anderson Cancer Center
Area of expertise
Colorectal Cancer
Christine Parseghian has run 6 trials for Colorectal Cancer. Some of their research focus areas include:
Colon Cancer
Christine Parseghian has run 4 trials for Colon Cancer. Some of their research focus areas include:
Affiliated Hospitals
M D Anderson Cancer Center
MD Anderson Cancer Center
Clinical Trials Christine Parseghian is currently running
Adagrasib + Cetuximab + Cemiplimab
for Colorectal Cancer
To learn if the drug combination of adagrasib, cetuximab, and cemiplimab can help to control metastatic CRC with KRAS G12C mutations.
Recruiting
1 award
Phase 1 & 2
6 criteria
Drug Combination
for Advanced Colorectal Cancer
To learn if avutometinib in combination with defactinib and cetuximab can help to control unresectable, anti-EGFR-refractory, advanced colorectal cancer.
Recruiting
1 award
Phase 2
More about Christine Parseghian
Clinical Trial Related
8 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Christine Parseghian has experience with
- Cetuximab
- Panitumumab
- Trametinib
- Adagrasib
- Cemiplimab
- Avutometinib
Breakdown of trials Christine Parseghian has run
Colorectal Cancer
Colon Cancer
Rectal Cancer
Epidermal Growth Factor Receptor Mutations
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Christine Parseghian specialize in?
Christine Parseghian focuses on Colorectal Cancer and Colon Cancer. In particular, much of their work with Colorectal Cancer has involved Stage IV patients, or patients who are NRAS negative.
Is Christine Parseghian currently recruiting for clinical trials?
Yes, Christine Parseghian is currently recruiting for 3 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Christine Parseghian has studied deeply?
Yes, Christine Parseghian has studied treatments such as Cetuximab, Panitumumab, Trametinib.
What is the best way to schedule an appointment with Christine Parseghian?
Apply for one of the trials that Christine Parseghian is conducting.
What is the office address of Christine Parseghian?
The office of Christine Parseghian is located at: M D Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the M D Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.